Cardiomedex is a highly skilled preclinical CRO specialized in the cardiovascular field. Cardiomedex conducts reliable studies that optimize the preclinical development of drug candidates for the treatment of cardiovascular diseases and cardiometabolic complications. Our large selection of gold standard animal models covers cardiovascular disorders such as: Heart failure with preserved or reduced ejection fraction Myocardial infarction Cardiac hypertrophy Hypertension Endothelial dysfunction Anthracycline cardiotoxicity Along with in vivo models, we offer a state-of-the-art platform for functional exploration & pharmacological characterization using ex-vivo and in vitro assays. In addition to CRO services, we provide our clients with personalized consulting services in line with the pharma industry’s emerging trends.
Looking for a particular Cardiomedex employee's phone or email?
The Cardiomedex annual revenue was $27.4 million in 2026.
Caroline Dubroca is the Director of Scientific Operations and Research Development of Cardiomedex.
9 people are employed at Cardiomedex.
Cardiomedex is based in Escalquens, Occitania.
The NAICS codes for Cardiomedex are [541713, 541, 54171, 5417, 54].
The SIC codes for Cardiomedex are [873, 87].